Sales and Marketing/ Views & Analysis/ Views and analysis Nine for 2021: Addressing the pandemic legacy mike.hammerton@pharmaphorum.com 2021, biologics, biosimilars, China, CNS, customer engagement, Nine for 2021 0 Comment In this second ‘Nine for 2021‘ article, IQVIA’s Sarah Rickwood looks at four issues which will directly impact Share X Nine for 2021: Addressing the pandemic legacy https://pharmaphorum.com/views-analysis-sales-marketing/nine-for-2021-pandemic-legacy/
Market Access/ Views & Analysis/ Views and analysis Nine for 2021: The COVID-19 legacy Catherine Longworth 2021, COVID-19, IQVIA, Nine for 2021, pandemic, Sarah Rickwood 0 Comment In the first of a two part series, IQVIA’s Sarah Rickwood covers nine key trends and events that Share X Nine for 2021: The COVID-19 legacy https://pharmaphorum.com/views-and-analysis/nine-for-2021-the-covid-19-legacy/
2021, biologics, biosimilars, China, CNS, customer engagement, Nine for 2021
0 Comment
